133 related articles for article (PubMed ID: 34793919)
1. Oral insulin delivery by epithelium microenvironment-adaptive nanoparticles.
Li J; Qiang H; Yang W; Xu Y; Feng T; Cai H; Wang S; Liu Z; Zhang Z; Zhang J
J Control Release; 2022 Jan; 341():31-43. PubMed ID: 34793919
[TBL] [Abstract][Full Text] [Related]
2. zwitterionic Pluronic analog-coated PLGA nanoparticles for oral insulin delivery.
Liu K; Chen Y; Yang Z; Jin J
Int J Biol Macromol; 2023 May; 236():123870. PubMed ID: 36870645
[TBL] [Abstract][Full Text] [Related]
3. Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin.
Yu F; Li Y; Liu CS; Chen Q; Wang GH; Guo W; Wu XE; Li DH; Wu WD; Chen XD
Int J Pharm; 2015 Apr; 484(1-2):181-91. PubMed ID: 25724135
[TBL] [Abstract][Full Text] [Related]
4. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.
Fan W; Xia D; Zhu Q; Li X; He S; Zhu C; Guo S; Hovgaard L; Yang M; Gan Y
Biomaterials; 2018 Jan; 151():13-23. PubMed ID: 29055774
[TBL] [Abstract][Full Text] [Related]
5. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
[TBL] [Abstract][Full Text] [Related]
6. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
[TBL] [Abstract][Full Text] [Related]
7. Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo.
Xu Q; Ensign LM; Boylan NJ; Schön A; Gong X; Yang JC; Lamb NW; Cai S; Yu T; Freire E; Hanes J
ACS Nano; 2015 Sep; 9(9):9217-27. PubMed ID: 26301576
[TBL] [Abstract][Full Text] [Related]
8. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
[TBL] [Abstract][Full Text] [Related]
9. Novel PLGA-based nanoparticles for the oral delivery of insulin.
Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S
Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248
[TBL] [Abstract][Full Text] [Related]
10. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
11. PEGylated DOX-coated nano graphene oxide as pH-responsive multifunctional nanocarrier for targeted drug delivery.
Ma K; Li W; Zhu G; Chi H; Yin Y; Li Y; Zong Y; Guo Z; Wang L; Xu W; Cui C; Zhou H; Xu J
J Drug Target; 2021 Sep; 29(8):884-891. PubMed ID: 33571019
[TBL] [Abstract][Full Text] [Related]
12. A pH-Triggered Self-Unpacking Capsule Containing Zwitterionic Hydrogel-Coated MOF Nanoparticles for Efficient Oral Exendin-4 Delivery.
Zhou Y; Chen Z; Zhao D; Li D; He C; Chen X
Adv Mater; 2021 Aug; 33(32):e2102044. PubMed ID: 34216408
[TBL] [Abstract][Full Text] [Related]
13. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
[TBL] [Abstract][Full Text] [Related]
14. Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery.
Wu J; Zheng Y; Liu M; Shan W; Zhang Z; Huang Y
ACS Appl Mater Interfaces; 2018 Mar; 10(12):9916-9928. PubMed ID: 29504398
[TBL] [Abstract][Full Text] [Related]
15. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
Shrestha N; Xu Y; Prévost JRC; McCartney F; Brayden D; Frédérick R; Beloqui A; Préat V
Acta Biomater; 2022 Mar; 140():561-572. PubMed ID: 34923097
[TBL] [Abstract][Full Text] [Related]
16. Scalable production of core-shell nanoparticles by flash nanocomplexation to enhance mucosal transport for oral delivery of insulin.
He Z; Liu Z; Tian H; Hu Y; Liu L; Leong KW; Mao HQ; Chen Y
Nanoscale; 2018 Feb; 10(7):3307-3319. PubMed ID: 29384554
[TBL] [Abstract][Full Text] [Related]
17. Design of smart GE11-PLGA/PEG-PLGA blend nanoparticulate platforms for parenteral administration of hydrophilic macromolecular drugs: synthesis, preparation and in vitro/ex vivo characterization.
Colzani B; Speranza G; Dorati R; Conti B; Modena T; Bruni G; Zagato E; Vermeulen L; Dakwar GR; Braeckmans K; Genta I
Int J Pharm; 2016 Sep; 511(2):1112-23. PubMed ID: 27511710
[TBL] [Abstract][Full Text] [Related]
18. A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery.
Liu Y; Li K; Liu B; Feng SS
Biomaterials; 2010 Dec; 31(35):9145-55. PubMed ID: 20864169
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Oral Delivery of Protein Drugs Using Zwitterion-Functionalized Nanoparticles to Overcome both the Diffusion and Absorption Barriers.
Shan W; Zhu X; Tao W; Cui Y; Liu M; Wu L; Li L; Zheng Y; Huang Y
ACS Appl Mater Interfaces; 2016 Sep; 8(38):25444-53. PubMed ID: 27588330
[TBL] [Abstract][Full Text] [Related]
20. A Nanocomposite Vehicle Based on Metal-Organic Framework Nanoparticle Incorporated Biodegradable Microspheres for Enhanced Oral Insulin Delivery.
Zhou Y; Liu L; Cao Y; Yu S; He C; Chen X
ACS Appl Mater Interfaces; 2020 May; 12(20):22581-22592. PubMed ID: 32340452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
